Stocksigma LogoStocksigma Logo

Bliss GVS Pharma Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)

■ Revenue: 31,337 (+28.2% YoY | +9.7% QoQ) ■ EBITDA: 8,058 (+85.3% YoY | +5.5% QoQ) ■ EBITDA Margin (%): 25.7 (+793 bps YoY | -104 bps QoQ) ■ PAT: 5,225

Bliss GVS Pharma Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)

Bliss GVS Pharma Ltd · Financial Result · 29 Oct 2026, 10:30 pm

Bliss GVS Pharma Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 31,337 (+28.2% YoY | +9.7% QoQ) ■ EBITDA: 8,058 (+85.3% YoY | +5.5% QoQ) ■ EBITDA Margin (%): 25.7 (+793 bps YoY | -104 bps QoQ) ■ PAT: 5,225 (+91.7% YoY | +4.3% QoQ) ■ EPS (INR): 4.81 (+89.4% YoY | +3.4% QoQ)

Original exchange filing (PDF)

More announcements from Bliss GVS Pharma Ltd

All Bliss GVS Pharma Ltd announcements